Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study

D. Thaçi*, K. Papp, D. Marcoux, L. Weibel, A. Pinter, P. D. Ghislain, I. Landells, P. H. Hoeger, K. Unnebrink, M. M.B. Seyger, D. A. Williams, S. Rubant, S. Philipp

*Corresponding author for this work
3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology